Dov Terkieltaub's Colleagues at Nucleix Ltd.
Michael Selitrennik
Product Development Scientist Team Leader at Nucleix Ltd.
Dov Terkieltaub's Contact Details
858-283-3398
Giv'at Shmuel,Center District,Israel
Nucleix Ltd.
Dov Terkieltaub's Company Details
Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS and PCR-based epigenetics, the Company's pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Company's non-invasive EpiCheck® platform delivers highly accurate and sensitive results, all while providing a seamless testing option for patients and the healthcare system. The Company is building an EpiCheck franchise, beginning with the Bladder EpiCheck® testing kit, marketed in Europe for bladder cancer recurrence. The Company is advancing a Lung EpiCheck test toward commercialization for high-risk individuals, while advancing additional tests for high-risk diseases.